| Literature DB >> 27933873 |
Mengqi Wang1, Yufei Xie1, Youxiu Zhong1,2, Juren Cen1,3, Lei Wang1, Yuanyuan Liu1, Ying Zhu1, Li Tong1, Qun Wei1.
Abstract
Isogarcinol is a new natural immunosuppressant that was extracted from Garcinia mangostana L. in our laboratory. Knowledge of its effects on treatable diseases and its mechanism of action is still very limited. In this study, we explored the therapeutic effect of isogarcinol in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS). Treatment with oral 100 mg/kg isogarcinol markedly ameliorated clinical scores, alleviated inflammation and demyelination of the spinal cord, and reduced intracranial lesions in EAE mice. The percentages of Th cells and macrophages were also strongly reduced. Isogarcinol appeared to act by inhibiting T helper (Th) 1 and Th17 cell differentiation via the janus kinase/signal transducers and activators of transcription pathway and by impairing macrophage function. Our data suggest that isogarcinol has the potential to be an effective therapeutic agent of low toxicity for treating MS and other autoimmune diseases.Entities:
Keywords: Garcinia mangostana L.; Jak/STAT pathway; cytokines; experimental autoimmune encephalomyelitis; isogarcinol; multiple sclerosis
Mesh:
Substances:
Year: 2016 PMID: 27933873 DOI: 10.1021/acs.jafc.6b04145
Source DB: PubMed Journal: J Agric Food Chem ISSN: 0021-8561 Impact factor: 5.279